Word: kidney
(lookup in dictionary)
(lookup stats)
Dates: during 1960-1969
Sort By: most recent first
(reverse)
Died. The Rev. Aloysius S. Travers, 75, Philadelphia Roman Catholic priest, whose ever so brief career as major-league pitcher accounts for one of baseball's oldest and least wanted records-most runs given up in nine innings; of a kidney ailment; in Philadelphia. On May 18, 1912, when the Detroit Tigers angrily refused to play a game with the Athletics (after Ty Cobb was suspended for hitting a fan three days before), Travers, then a student at Philadelphia's St. Joseph's College, was one of a group of sandlotters recruited to face...
...dogs. At its pet-care center near St. Louis, for example, some 450 dogs and 250 cats slurp and chew Purina pet foods. Sniffing a trend toward "gourmet" dishes for discriminating dogs, Voila Foods for Pets, Inc., was founded this year to market burgundy beef in gravy and beef-kidney stew...
...organ bank from which surgeons could draw a kidney, a liver or a heart for transplantation when needed is still far off in the future, but an information bank from which surgeons may find out about organs as they become available is in the process of being established. Sponsor of the bank-or, more precisely, clearinghouse-is the Medic Alert Foundation. Started on a shoestring twelve years ago in Turlock, Calif., by Dr. Marion Collins, the organization has by now issued something like 200,000 identification bracelets and necklace tags to victims of diabetes, hemophilia, penicillin allergy and other conditions...
...based upon a virus strain isolated by Pediatricians Harry M. Meyer Jr. and Paul D. Parkman at the National Institutes of Health. Merck Sharp & Dohme grows the attenuated (weakened though still "live") virus in fertilized duck eggs; Eli Lilly & Co. grows it in cultures of monkeys' kidney cells, while Philips Roxane Laboratories uses dogs' kidney cells. All told, the three companies have had about 20,000 children inoculated in pilot studies...
...fourth vaccine, made in Belgium from a different strain of virus and grown in rabbits' kidney cells, is presently being tested for eventual marketing in the U.S. by Smith Kline & French Laboratories. This vaccine will probably be licensed in Europe by year's end, though U.S. approval will take longer. With four arrows in their quiver, U.S. public health authorities are confident that safe and effective vaccines to be given men and children will be approved in time to prevent future epidemics and thus drastically reduce, if not altogether eliminate, the ravages of rubella against the unborn...